Published in Cell Immunol on June 01, 1984
THE PRODUCTION OF CARDIAC LESIONS BY REPEATED INJECTIONS OF DESOXYCORTICOSTERONE ACETATE. J Clin Invest (1942) 12.64
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
A New Penicillin for Prolonged Blood Levels. Science (1948) 5.66
Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. BMJ (1992) 5.58
Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Curr Top Microbiol Immunol (1978) 4.88
General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice. Clin Exp Immunol (1969) 4.00
Assessing B cell diversification by antigen receptor and precursor cell analysis. Ann Immunol (Paris) (1976) 3.88
Diagnosis of impaired fetal growth in newborn infants. Pediatrics (1971) 3.62
The mechanism of antigenic stimulation of primary and secondary clonal precursor cells. J Exp Med (1972) 3.41
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
In vitro tolerance induction of neonatal murine B cells. J Exp Med (1976) 2.33
The characterization fo the B-cell repertoire specific for the 2,4-dinitrophenyl and 2,4,6-trinitrophenyl determinants in neonatal BALB/c mice. J Exp Med (1975) 2.32
High-frequency transfection of CHO cells using polybrene. Somat Cell Mol Genet (1986) 2.29
Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. Am J Cardiol (1979) 2.20
Antigen-independent changes in naive CD4 T cells with aging. J Exp Med (1996) 2.14
Segregation at a locus determining an immunoglobulin genetic marker for the light chain variable region affects inheritance of expression of an idiotype. Proc Natl Acad Sci U S A (1977) 1.97
Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell. Proc Natl Acad Sci U S A (1975) 1.96
The B cell specificity repertoire: its relationship to definable subpopulations. Transplant Rev (1975) 1.87
Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses. J Exp Med (1976) 1.87
Congenital defects in the diaphragm. Am J Pathol (1940) 1.86
The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses. J Exp Med (1975) 1.83
The analysis of the monoclonal immune response to influenza virus. I. Production of monoclonal anti-viral antibodies in vitro. Eur J Immunol (1975) 1.81
Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations. Cell (1989) 1.81
Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level. J Exp Med (1975) 1.75
Decreased frequency of somatic hypermutation and impaired affinity maturation but intact germinal center formation in mice expressing antisense RNA to DNA polymerase zeta. J Immunol (2001) 1.74
Antibody with homogeneous antigen binding produced by splenic foci in organ culture. Immunochemistry (1969) 1.73
The diversity of the influenza-specific primary B-cell repertoire in BALB/c mice. J Exp Med (1978) 1.69
The stimulation of splenic foci in vitro. J Immunol (1971) 1.59
The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. J Immunol (1975) 1.55
B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol (1999) 1.54
Frequency of hapten-specific B cells in neonatal and adult murine spleens. Eur J Immunol (1974) 1.54
Cellular immunity to Leishmania donovani in macrophages in cultures. J Parasitol (1969) 1.49
Differential expression of an equivalent clonotype among BALB/c and C57BL/6 mice. J Exp Med (1978) 1.49
Antibody-specific immunoregulation. J Exp Med (1977) 1.48
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. J Urol (1995) 1.47
A microtest radioimmunoassay for noncytotoxic tumor-specific antibody to cell-surface antigens. J Natl Cancer Inst (1973) 1.46
Monoclonal production of both IgM and IgG1 antihapten antibody. J Exp Med (1973) 1.45
Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J (Clin Res Ed) (1986) 1.44
Comparison of formulae used to estimate oxygen saturation of mixed venous blood from caval samples. Br Heart J (1974) 1.44
Equine anti-hapten antibody. 3. The comparative properties of gamma G- and gammaA-antibodies. J Immunol (1966) 1.43
The effect of race on the incidence of low birth weight: persistence of effect after controlling for socioeconomic, educational, marital, and risk status. Yale J Biol Med (1987) 1.42
Peripheral and autonomic neuropathy after treatment with perhexiline maleate. Br Med J (1977) 1.42
Health services for children in some western European countries: their significance for the United States. Pediatrics (1968) 1.41
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Delays in admission of patients with acute myocardial infarction to coronary care: implications for thrombolysis. Health Bull (Edinb) (1990) 1.34
Role of echocardiography and phonocardiography in diagnosis of mitral paraprosthetic regurgitation with Starr-Edwards prostheses. Br Heart J (1973) 1.33
Isoelectric analysis of neonatal monofocal antibody. Immunochemistry (1973) 1.29
Overlap stimulation of primary and secondary B cells by cross-reacting determinants. J Exp Med (1973) 1.27
Recovery of antibody activity upon reoxidation of completely reduced polyalanyl heavy chain and its Fd fragment derived from anti-2,4-dinitrophenyl antibody. Biochemistry (1968) 1.26
In vitro tolerance induction of bone marrow cells: a marker for B cell maturation. J Immunol (1977) 1.26
Enumeration and analysis of antibody-forming cell precursors in the neonatal mouse. J Immunol (1973) 1.25
Regain of homogeneous binding activity after recombination of chains of "mono- focal" antibody. J Immunol (1971) 1.25
alpha1-Antitrypsin is an effector of immunological stasis. Nature (1978) 1.25
Patterned acquisition of the antibody repertoire: diversity of the hemagglutinin-specific B-cell repertoire in neonatal BALB/c mice. Proc Natl Acad Sci U S A (1979) 1.24
Defining the heterogeneity of anti-tumor antibody responses. J Immunol (1976) 1.20
Purification and analysis of "monofocal" antibody. J Immunol (1971) 1.19
Density gradient separation of marrow cells restricted for antibody class. Science (1971) 1.19
Among naive precursor cell subpopulations only progenitors of memory B cells originate germinal centers. Eur J Immunol (1992) 1.19
Expression of phosphorylcholine-specific B cells during murine development. J Exp Med (1977) 1.19
Expression of Ia antigens on hapten-specific B cells. I. Delineation of B-cell subpopulations. J Exp Med (1976) 1.18
The expression of the Ig H chain repertoire in developing bone marrow B lineage cells. J Immunol (1991) 1.17
The secondary immune response to a hapten in vitro. Antigen concentration and the carrier effect. J Exp Med (1971) 1.17
Tolerance susceptibility of newly generating memory B cells. J Immunol (1991) 1.17
Role of the major histocompatibility gene products in regulating the antibody response to dinitrophenylated poly(L-Glu55,L-Ala35,L-Phe9)n. J Exp Med (1980) 1.16
The B-cell clonotype repertoire. Adv Immunol (1978) 1.16
The monoclonal anti-phosphorylcholine antibody response in several murine strains: genetic implications of a diverse repertoire. J Exp Med (1977) 1.15
Protein glycosylation and myristylation in Chlorella virus PBCV-1 and its antigenic variants. Virology (1994) 1.14
Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J Exp Med (1982) 1.14
Suppressive activity of splenic adherent cells from Plasmodium chabaudi-infected mice. J Immunol (1980) 1.13
Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes. Proc Natl Acad Sci U S A (1986) 1.13
Tolerance as an active process. Nature (1980) 1.10
Immunoglobulin class commitment exhibited by B lymphocytes separated according to surface isotype. J Immunol (1981) 1.10
Hapten-specific stimulation of secondary B cells independent of T cells. J Exp Med (1973) 1.10
The murine B cell repertoire responsive to an influenza-infected syngeneic cell line. J Immunol (1981) 1.10
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep (1980) 1.09
Perinatal and environmental factors in late neurogenic sequelae. I. Infants having birth weights under 1,500 grams. Am J Dis Child (1966) 1.09
Reaction of polyglycolic acid sutures in the urinary tract. Comparison with chromic catgut sutures. Urology (1973) 1.07
Evidence for virus-encoded glycosylation specificity. Proc Natl Acad Sci U S A (1993) 1.06
Brain and thymus lipid inhibition of antibrain-associated theta-cytotoxicity. J Exp Med (1974) 1.06
Postnatal somatic growth in infants with atypical fetal growth patterns. Am J Dis Child (1977) 1.06
Modulation of the immune response by antigen-reactive lymphocytes after cultivation with gangliosides. J Immunol (1975) 1.06
The assessment of left ventricular ejection fraction in patients with ischaemic heart disease by contrast ventriculography and nuclear angiography. Clin Sci Mol Med (1977) 1.05
Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol (1995) 1.05
Late acquisition of a germ line antibody specificity. Nature (1976) 1.05
Permanent pacing. Br Med J (Clin Res Ed) (1987) 1.04
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res (1993) 1.04
T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction. J Immunol (1989) 1.02
Antigen-specific cells in mouse bone marrow. I. Lasting effects of priming on immunocyte production by transferred marrow. J Exp Med (1970) 1.02
Fetal malnutrition in white newborn infants: maternal factors. Pediatrics (1973) 1.02
A model for studying the pathogenesis and incidence of low-birth-weight infants. Am J Dis Child (1983) 1.02
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect Immun (1994) 1.01
The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J Biol Chem (1991) 1.01
Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains. J Immunol (1998) 1.00
Products of linoleic hydroperoxide-decomposing enzyme of alfalfa seed. J Lipid Res (1974) 1.00
T-cell and B-cell responses to viral antigens at the clonal level. Annu Rev Immunol (1983) 0.99
The management of ventricular septal rupture following myocardial infarction. Q J Med (1980) 0.99
The role of antibody bivalence in the neutralization of bacteriophage. J Immunol (1967) 0.99
Antigen responsiveness of the mature and generative B cell populations of aged mice. J Exp Med (1983) 0.98